Goa-based Molbio Diagnostics, backed by Temasek Holdings subsidiary and Motilal Oswal Private Equity, has filed draft papers with SEBI to launch its Initial Public Offering (IPO). The issue will comprise a fresh issue of ₹200 crore and an offer-for-sale (OFS) of up to 1.25 crore equity shares.
According to the draft filed on August 22, existing shareholders, including promoters and investors, will participate in the OFS. Promoters Exxora Trading LLP and Chandrasekhar Bhaskaran Nair, who jointly hold a 46.65% stake, plan to offload 29.12 lakh shares.
Meanwhile, investors holding a combined 53.35% stake — including V Sciences Investments, India Business Excellence Fund III, Gopalkrishna Mangalore Kini, Gopalakrishna Sampathgiri, J Guru Dutt, Sangeetha M Kini, and MA Usha Rani — will divest 96.44 lakh shares through the OFS route.